JPMorgan Chase & Co’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62
| Closed | -$45 | – | 6656 |
|
|
2025
Q1 | $45 | Sell |
62
-4
| -6% | -$3 | ﹤0.01% | 6123 |
|
|
2024
Q4 | $63 | Sell |
66
-9
| -12% | -$9 | ﹤0.01% | 6034 |
|
|
2024
Q3 | $59 | Buy |
75
+16
| +27% | +$13 | ﹤0.01% | 6016 |
|
|
2024
Q2 | $56 | Sell |
59
-2,685
| -98% | -$2.55K | ﹤0.01% | 5985 |
|
|
2024
Q1 | $2.96K | Sell |
2,744
-113
| -4% | -$122 | ﹤0.01% | 5518 |
|
|
2023
Q4 | $1.57K | Buy |
2,857
+135
| +5% | +$74 | ﹤0.01% | 5723 |
|
|
2023
Q3 | $5.74K | Buy |
2,722
+21
| +0.8% | +$44 | ﹤0.01% | 5412 |
|
|
2023
Q2 | $7.08K | Hold |
2,701
| – | – | ﹤0.01% | 5219 |
|
|
2023
Q1 | $9K | Hold |
2,701
| – | – | ﹤0.01% | 5297 |
|
|
2022
Q4 | $7K | Sell |
2,701
-3
| -0.1% | -$8 | ﹤0.01% | 5168 |
|
|
2022
Q3 | $8K | Sell |
2,704
-31
| -1% | -$92 | ﹤0.01% | 5111 |
|
|
2022
Q2 | $8K | Sell |
2,735
-2,109
| -44% | -$6.17K | ﹤0.01% | 5226 |
|
|
2022
Q1 | $34K | Sell |
4,844
-6,842
| -59% | -$48K | ﹤0.01% | 5137 |
|
|
2021
Q4 | $187K | Buy |
+11,686
| New | +$187K | ﹤0.01% | 4580 |
|